Cargando…

Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience

BACKGROUND: Men diagnosed with prostate cancer are at risk for competing morbidity and mortality due to cardiometabolic disease given their advanced age at diagnosis, high prevalence of pre-existing risk factors, and receipt of systemic therapy that targets the androgen receptor (AR). Expert panels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hahn, Andrew W., Thoman, Whittney, Koutroumpakis, Efstratios, Abdulla, Amer, Subudhi, Sumit K., Aparicio, Ana, Basen-Enngquist, Karen, Logothetis, Christopher J., Gilchrist, Susan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498569/ https://www.ncbi.nlm.nih.gov/pubmed/37705024 http://dx.doi.org/10.1186/s40959-023-00186-x

Ejemplares similares

Review of Immune-Related Adverse Events in Prostate Cancer Patients Treated with Ipilimumab: MD Anderson Experience
por: Gao, Jianjun, et al.
Publicado: (2015)

Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors
por: Coletta, Adriana M., et al.
Publicado: (2019)

M.D. Anderson, Oncología /
Publicado: (2000)

M.D. Anderson Cancer Center, oncología quirúrgica /
Publicado: (2005)

Cardiovascular Prevention Strategies in Breast Cancer
por: Yin, Alexandra B., et al.
Publicado: (2019)

ETMR-04. EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: THE MD ANDERSON CANCER CENTER EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020)

Neoadjuvant treatment: the MD Anderson experience
por: Hortobagyi, GN
Publicado: (2005)

EPEN-10. SPINAL MYXOPAPILLARY EPENDYMOMA AND METHYLATION-PROFILING: THE MD ANDERSON CANCER CENTER (MDACC) EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020)

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
por: Conter, Henry J., et al.
Publicado: (2014)

Making Cancer History: Disease and Discovery at the University of Texas M.D. Anderson Cancer Center
por: Hyland, Callen
Publicado: (2010)

Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience
por: Chang, Edward I., et al.
Publicado: (2020)

A longitudinal study of the Swedish MD Anderson Dysphagia Inventory in patients with oral cancer
por: Tuomi, Lisa, et al.
Publicado: (2020)

Obituary Notice of Thomas Anderson, M.D., F.L.S.
Publicado: (1870)

Book Reviews: Making Cancer History: Disease and Discovery at the University of Texas MD Anderson Cancer Center
por: Barnes, Emm
Publicado: (2011)

Validity and Reliability of the Korean Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients
por: Kwon, Chan-Hyuk, et al.
Publicado: (2013)

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes
por: Kuerer, Henry M., et al.
Publicado: (2017)

Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
por: Edwards, Beatrice J., et al.
Publicado: (2017)

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience
por: Tarek, Nidale, et al.
Publicado: (2020)

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting
por: Kamal, Mona, et al.
Publicado: (2022)

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
por: Mendoza, Tito, et al.
Publicado: (2020)

Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
por: Tzeng, Ching-Wei D., et al.
Publicado: (2020)

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
por: Nardo, Mirella, et al.
Publicado: (2023)

2589. Legionella pneumonia in cancer patients: 12-year experience at MD Anderson Cancer Center 2009-2021
por: Matsuo, Takahiro, et al.
Publicado: (2023)

Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
por: Yao, Shuyang, et al.
Publicado: (2022)

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience
por: Gregory, Timothy A, et al.
Publicado: (2023)

Mario A. Luna, M.D. The University of Texas M.D. Anderson Cancer Center (January 21, 1935 to November 9, 2008)
por: El-Naggar, Adel K., et al.
Publicado: (2009)

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
por: Goldstein, Jennifer B., et al.
Publicado: (2017)

457 Actinomyces Infection in Hematologic and Solid Cancer Patients at the University of Texas MD Anderson Cancer Center in 1998-2014
por: Gutierrez, Andres, et al.
Publicado: (2014)

Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
por: El Hussein, Siba, et al.
Publicado: (2020)

Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
por: Dembla, Vikas, et al.
Publicado: (2018)

Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI)
por: Mott, Frank E., et al.
Publicado: (2020)

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience
por: Majd, Nazanin K, et al.
Publicado: (2021)

Translation and Validation of the Indonesian MD Anderson Dysphagia Inventory (MDADI) in Head and Neck Cancer Patients with Swallowing Disorders
por: Fakhriani, Rizka, et al.
Publicado: (2021)

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience
por: Wang, Zhijie, et al.
Publicado: (2016)

The Pioneer of Women Practitioners: Elizabeth Garrett Anderson, M.D. Paris, L.S.A.
Publicado: (1917)

LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
por: Sinicrope, Kaylyn D, et al.
Publicado: (2019)

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Psychometric Properties of MD Anderson Symptoms Inventory for Acute Myeloid Leukemia Patients in Thailand
por: Rattanathammethee, Thanawat, et al.
Publicado: (2022)

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
por: Jabbour, Elias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qup421mcv38vctbe555o7n47cl